Behavioral Issues: How Pharma Can Rethink Change Management

Up to 70% of corporate change initiatives fail, notes Bill Wilder, director of the Life Cycle Institute, the training arm of Life Cycle Engineering (LCE). Oftentimes, it is because pharmaceutical and other manufacturers focus on products and processes, but not on people. Contrary to popular opinion, people generally don’t resist change, says Wilder. “They resist being changed when they don't know why.” In this interview, Wilder shares insights into how drug manufacturers can better manage change and strengthen their organizations from within.